A 66‐year‐old male with newly diagnosed IgA kappa multiple myeloma (International Staging System stage 3 with intermediate risk cytogenetics) developed swelling and pain at biopsy puncture site on day (D) 9 following an uneventful bone marrow aspirate and trephine biopsy (BMAT). The gene discussed is CD79A; the disease is plasma cell myeloma.